Search Within

Jeremy J Pappacena

  1. "DigITs Research Group"
Formats
  1. Meeting Abstract (3)
Groups
  1. Bone Marrow Transplant (3)
  2. Center for Hematologic Malignancies (3)
  3. Department of Medicine (3)
  4. DigITs Research Group (3)
  5. Hematologic Malignancies, Division of (3)
  6. Survivorship Research (3)

More Groups

People
  1. Larry Buie (3)
  2. Molly Maloy (3)
  3. Patrick Hilden (3)
  4. Valkal Bhatt (3)
  5. Gunjan Shah (2)
  6. Michael Scordo (2)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (2)
  2. Blood (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Society of Hematology (1)

Results (3)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Busulfan/melphalan/fludarabine (Bu/Mel/Flu) conditioning versus total body irradiation/thiotepa/cyclophosphamide (HFTBI/Thio/Cy) based conditioning in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing CD34-selected T-cell depleted allogeneic stem cell transplantation (alloSCT)
    Meeting Abstract

    Orozco, J. S.; Hilden, P.; Maloy, M. A.; Pappacena, J.; Buie, L. W.; Shaffer, B. C.; Papadopoulos, E. B.; Jakubowski, A. A.; Bhatt, V.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Blood (2017)

    Fulltext@MSK | Save